We’re sorry, something doesn't seem to be working properly.
Please try refreshing the page. If that doesn't work, please contact us so we can address the problem.
Folding machineries displayed on a cation-exchanger for the concerted refolding of cysteine- or proline-rich proteins
© Lee et al; licensee BioMed Central Ltd. 2009
Received: 17 September 2008
Accepted: 26 March 2009
Published: 26 March 2009
Escherichia coli has been most widely used for the production of valuable recombinant proteins. However, over-production of heterologous proteins in E. coli frequently leads to their misfolding and aggregation yielding inclusion bodies. Previous attempts to refold the inclusion bodies into bioactive forms usually result in poor recovery and account for the major cost in industrial production of desired proteins from recombinant E. coli. Here, we describe the successful use of the immobilized folding machineries for in vitro refolding with the examples of high yield refolding of a ribonuclease A (RNase A) and cyclohexanone monooxygenase (CHMO).
We have generated refolding-facilitating media immobilized with three folding machineries, mini-chaperone (a monomeric apical domain consisting of residues 191–345 of GroEL) and two foldases (DsbA and human peptidyl-prolyl cis-trans isomerase) by mimicking oxidative refolding chromatography. For efficient and simple purification and immobilization simultaneously, folding machineries were fused with the positively-charged consecutive 10-arginine tag at their C-terminal. The immobilized folding machineries were fully functional when assayed in a batch mode. When the refolding-facilitating matrices were applied to the refolding of denatured and reduced RNase A and CHMO, both of which contain many cysteine and proline residues, RNase A and CHMO were recovered in 73% and 53% yield of soluble protein with full enzyme activity, respectively.
The refolding-facilitating media presented here could be a cost-efficient platform and should be applicable to refold a wide range of E. coli inclusion bodies in high yield with biological function.
Escherichia coli retains its dominant position as the first choice of host for the high-throughput production of proteins of therapeutic or commercial interest because of rapid biomass accumulation, well-established genetic manipulation methods and simple process scale-up [1, 2]. However, a major disadvantage derived from the intrinsic properties of E. coli is the frequent formation of an inclusion body, a dense aggregate of misfolded polypeptides . Refolding the inclusion bodies into the native conformation might be straightforward if an efficient refolding scheme is established. There are a variety of conventional methodologies for refolding recombinant proteins from inclusion bodies, which contains simple dilution, dialysis and chromatographic refolding methods. Dilution is the simplest and most widely used technique and involves refolding initiation by reducing the denaturant concentration. However, the target product in dilution refolding can be obtained only very low yield because of protein aggregation at high protein concentration. Column-based refolding is the most likely to renaturate the protein aggregates at high concentration and to reduce the cost for reagents and buffers in large-scale protein refolding . Although these conventional methods are commonly used for protein refolding and quite progress has been made, disulfide bond formation and peptidyl-prolyl cis-trans isomerization have often frustrated the successful refolding of insoluble recombinant proteins containing cysteine and proline in multiple numbers [5, 6]. Generation of correct disulfide bonds and peptidyl-prolyl cis-trans configuration are required processes for formation and stabilization of the native protein conformation. Furthermore, the kinetics and thermodynamics of disulfide bond formation and peptidyl-prolyl cis-trans isomerization can dominate the rate and pathway of protein folding and in turn determine the refolding efficiency [7, 8].
At least two classes of cellular factors are currently known to assist in vivo or in vitro protein folding. The first class includes a number of proteins collectively known as "molecular chaperones" such as GroEL-GroES and DnaK/DnaJ/GrpE in E. coli. Molecular chaperones are believed to prevent undesirable folding pathways such as premature folding, aggregation and misfolding and thereby facilitate formation of biologically active protein structures . The second class contains foldases that catalyze protein folding by stimulating rate-limiting reactions such as the formation and interchange of disulfide bonds and isomerization of peptidyl-prolyl bonds . The respective enzymes are protein disulfide bond isomerase and peptidyl-prolyl cis-trans isomerase (PPIase). Recently, the application of these proteins in helping in vitro protein refolding has been studied actively [10, 11]. GroEL monomer is composed of three domains: an apical domain that is responsible for binding substrate , an equatorial domain that contains the ATP-binding site, and an intermediate hinge domain that connects the apical and equatorial domains. The monomeric apical domain of GroEL (mini-chaperone or mini-GroEL) was proved to trigger the in vitro refolding of rhodanase and cyclophilin A without GroES and ATP and had the activity of intact GroEL in vivo . The immobilized mini-chaperone and foldases were successfully employed in column chromatography and batchwise mode to refold indole 3-glycerol phosphate synthase, cyclodextrin glycosyltransferase, antibody fragments and the scorpion toxin Cn5 in high yield with biological activity [13–16].
Here, we report a simple method that enables one-step purification and immobilization of folding machineries (mini-chaperone, DsbA and human PPIase) simultaneously in fully functional forms using the positively-charged consecutive 10-arginine tag at their C-terminal. Further, the folding-catalytic matrices immobilized with mini-chaperone and/or two foldases were recruited to refold two denatured and reduced model proteins containing multiple cysteine or proline residues for proving their refolding-assisting efficiency. This report provides an affordable refolding method using immobilized folding machineries to lead the rapid provision of the protein of interest from inclusion bodies produced in E. coli.
Preparation of folding machineries
Construction of refolding matrices
Functional analyses of immobilized folding machineries
Batchwise refolding of denatured and reduced proteins
Batchwise refolding of denatured and reduced RNase A and CHMO.
Refolding yield* (%)
Activity yield† (%)
Refolding yield (%)
Activity yield (%)
SP Sepharose Fast Flow alone (control)
17.2 ± 1.4
33 ± 3
2.1 ± 0.7
17 ± 2
Single refolding matrix
55.0 ± 2.1
98 ± 5
31.0 ± 1.6
107 ± 6
57.6 ± 2.4
121 ± 12
8.5 ± 1.3
99 ± 3
67.0 ± 3.3
115 ± 9
11.0 ± 2.2
103 ± 8
Binary refolding matrix
Mini-chaperone + DsbA
68.0 ± 1.8
107 ± 5
27.1 ± 2.4
109 ± 11
Mini-chaperone + hPPIase
56.7 ± 2.7
118 ± 7
46.2 ± 1.8
123 ± 8
DsbA + hPPIase
58.4 ± 2.6
126 ± 2
13.8 ± 1.5
111 ± 10
Ternary refolding matrix
Mini-chaperone + DsbA + hPPIase
73.0 ± 1.5
131 ± 3
53.0 ± 2.7
125 ± 4
CD analysis of refolded proteins
Protein aggregation during production and refolding from the inclusion body of many industrial and pharmaceutical proteins in E. coli has been a major technical and economical bottleneck that has spurred basic research as well as process development . Among various approaches to overcome protein aggregation in refolding processes, refolding chromatography systems mimicking in vivo folding systems are introduced as an efficient and simple way to renature proteins in high yields [13, 16]. However, refolding reaction stoichiometry requires a considerable amount of folding machineries . Therefore, a cost-efficient purification and immobilization of folding machineries is a critical step in order to apply this refolding methodology to a large bioprocess scale. Previously, protein disulfide isomerase (PDI) has been immobilized only in low yield and is not active . It is mainly due to very reactive thiol groups in PDI. Altamirano et al.  reported the first successful immobilization of DsbA as a fully functional form. They could immobilize the DsbA on agarose by transiently blocking the active site by cyanylation. However, this technique is still challenging to repeat and cost-inefficient. In this study, we report a simple method that enables simultaneous purification and immobilization of folding machineries in fully functional forms. Among a variety of immobilization methods, adsorption is simpler and less expensive, with minimal chemical requirements and less likelihood of enzyme denaturation. However, the weak nature of the binding forces can cause leakage of the enzyme with changes in pH, ionic strength and/or temperature. In order to prevent leakage of proteins from the solid support and to exploit the simple adsorption method, the folding catalysts were charged by attaching 10-arginine amino acids. Specifically, the charged consecutive Arg10-stretch was genetically fused to the C-terminal of the mini-chaperone, DsbA and hPPIase to generate the charge-added folding catalysts. The generated folding catalysts were analyzed for their purification and immobilization characteristics. A single ion-exchange chromatography was performed for the one-step purification of the soluble folding machineries. Most intracellular proteins of E. coli have their isoelectric points (pI) at weak acidic pH in analysis of the wild type E. coli proteome . Ninety-seven percent of intracellular proteins have pI values below pH 8.4, the same pH value of loading buffer, with only 3% at basic pH. It indicates that more than 97% E. coli proteins are negatively charged at pH 8.4 and cannot be bound on a cation exchanger. The calculated pI values of mini-chaperone, DsbA and hPPIase with Arg10 stretch was 9.43, 9.41 and 10.23, respectively, implying that the folding machineries have positive charges in 50 mM sodium phosphate buffer, pH 8.4. Therefore, they were easily purified with high purity form the negatively charged intracellular E. coli proteins using a single step of cation exchange chromatography. Further, Arg10-tail provided a simple and firm strategy for the immobilization of folding machineries. Efficient immobilization of folding machineries on a cation exchanger was achieved using an adsorption based on electrostatic interaction. The maximum amounts of the immobilized folding machinery reached 10.8 – 12.2 mg/ml and were higher than those of other groups reported previously . The immobilized mini-chaperone and foldases were fully functional when assayed in a batch mode. The targeted benefit of immobilization of folding catalysts is easy separation of the refolded protein from the other components and the immobilization procedure increases the efficiency of the folding machineries, since higher concentrations of the active folding machineries can be achieved in the gel than in solution.
Recombinant proteins of industrial and pharmaceutical interest may have disulfide bonds and many are difficult to refold. After successful purification and immobilization of folding catalysts, we applied immobilized mini-chaperone and foldases to refold the cysteine- and proline-rich proteins. The first model protein is bovine pancreatic RNase A consisting of 124 amino acid residues and contains 8 cysteine residues involving in formation of 4 intramolecular disulfide bonds and 5 proline residues. The remarkable renaturation was achieved when the unfolded RNase A was treated with the individual immobilized folding machinery, suggesting that the immobilization of folding machineries on a cation exchanger through 10-arginine fusion did not inhibit their chaperone activity. This result contrasts with the spontaneous renaturation by the SP Sepharose Fast Flow in refolding buffer (Table 1). In addition, combination of the appropriate amounts of each gel makes it easier to find the optimal refolding conditions of the other target proteins because each gel has a similar refolding efficiency. The complete refolding matrices (mini-chaperone/DsbA and mini-chaperone/DsbA/hPPIase) proved to be highly efficient (68% and 73%, respectively) in restoring the native structure and biological properties of the RNase A. The synergistic effect of DsbA with PPIase and of GroEL with PDI has been observed in vivo and in vitro, indicating that they play cooperative roles in protein refolding [23, 24]. The refolded RNase A recovers a native-like secondary structure based on its similar CD spectrum to that of native RNase A. The second model protein, CHMO derived from Acinetobacter sp. is one of the oxidative enzymes of special interest as a biocatalyst in the NADPH-dependent oxidation of cyclohexanone to ε-caprolactone via a Baeyer-Villiger mechanism. It comprises 543 amino acids and contains 5 cysteines and 22 prolines. When the disulfide bonds prediction was performed using DiANNA, which is recent state-of-the-art web-based software determining the cysteine oxidation state and disulfide connectivity of a protein , the result showed that 4 of 5 cysteine residues might be involved in the formation of two intramolecular disulfide bonds (Cys330-Cyss475 and Cys376-Cys520). The CHMO deposited as inclusion bodies in recombinant E. coli could be refolded with 53% yield using the ternary refolding matrices (mini-chaperone/DsbA/hPPIase-Sepharose) while the negligible refolding yield was achieved using the SP Sepharose resin alone. The other refolding matrices also assisted the batchwise mode of CHMO refolding (Table 1).
This work demonstrates that a commonly used and relatively inexpensive ion-exchange matrix can be used for immobilization of folding catalysts. Refolding was not inhibited by protein-matrix interactions thus preventing the need for tagged protein in an affinity based method. Refolded protein was directly obtained from the refolding matrix in a highly concentrated form and free from incorrectly or incompletely refolded protein. This indicates that the proposed method can contribute significantly to bioprocess intensification as it integrates the reducing-agent removal, refolding, concentration and purification unit operations used in dilution refolding into an easily automated process. Therefore, the method is an interesting alternative for large-scale or preparative oxidative refolding of complex and highly disulfide-bonded proteins. Results reported here showed an effective refolding technique for proline- or cysteine-rich proteins obtained from E. coli inclusion bodies, which might be potential in the biotechnology industry.
Oligonucleotides were synthesized by Bioneer (Daejeon, Korea). All restriction enzymes were from New England Biolabs. The vector pET-29b(+) was obtained from Novagen. E. coli DH5α and BL21(DE3) cells were used for maintenance of plasmids and for the production of recombinant proteins, respectively. Plasmid, gel extraction and PCR purification kits were purchased from Qiagen. RNase A type XII-A from bovine pancreas, RNase A with scrambled disulfide bonds, cyclohexanone monooxygenase (CHMO) of Acinetobacter sp. expressed in recombinant E. coli, cytidine 2', 3'-cyclic monophosphate (2', 3'-cCMP), N-Succinyl-Ala-Ala-Pro-Phe-p-nitroanilide (N-Suc-AAPF-p-nitroanilide) and α-chymotrypsin (α-CT) were purchased from Sigma-Aldrich. All other chemicals unless otherwise stated were of reagent grade.
Construction of template plasmid with Arg10-tag
Oligonucleotide sequences used in this study.
Sequence of oligonucleotide
Construction of expression plasmids
To construct expression vectors for folding machineries with C-terminal Arg10-tag, genes for mini-chaperone, DsbA and hPPIase were amplified by PCR from the chromosomal DNA of E. coli K-12 or from the cDNA of hPPIase gene as template. The primer sets used for amplification of folding machineries are as follows: Mini5 and Mini3 for mini-chaperone; DsbA5 and DsbA3 for DsbA; HPPI5 and HPPI3 for hPPIase (Table 2). The amplified DNA fragments were digested by NdeI and BamHI and cloned into the template vector pETR10 digested by the same restriction enzymes. The resulting 3 expression vectors are named as pMiniELR10, pDsbAR10, and pHPPIR10, respectively.
Expression and purification of folding machineries
In order to prepare the folding machineries, E. coli BL21(DE3) cells harboring expression vectors for folding machineries were cultured in 200 ml Luria-Bertani (LB) medium (0.5% yeast extract, 1% tryptone and 1% NaCl) supplemented with 50 μg/ml kanamycin at 30°C and induced with 0.5 mM isopropyl-β-thiogalactopyranoside (IPTG) at an OD600 of 0.5. After 6 hr induction, cells were harvested by centrifugation at 8000 × g for 30 min at 4°C. The harvested cells were resuspended in 20 ml of 50 mM sodium phosphate buffer, pH 8.4 and then disrupted by French Press (Thermo Spectronic) at 20,000 psi in an ice bath. After removing cell debris by centrifugation, the resulting supernatant was directly loaded onto an ion-exchange column for purification. An automated chromatography system, ÄKTA prime (GE Healthcare Life Sciences) was used to monitor the protein elution peak. The ion-exchange column, HiTrap Sepharose Fast Flow (GE Healthcare Life Sciences) loaded with E. coli cell extracts was washed with 10 column volumes of 50 mM sodium phosphate buffer, pH 8.4 at a flow rate of 1.0 ml/min. The unbound proteins were washed out at this step. Continuous linear gradient from 0 to 1 M NaCl was applied to separate the proteins bound to the cation exchanger. The absorbance at 280 nm and the conductivity in the eluent were observed. The final eluted fractions were collected and subjected to further analyses.
Protein quantification and detection
Protein concentration was determined by the Bradford method using the protein assay kit (Bio-Rad) according to the manufacturer's instructions. Protein samples were analyzed by SDS-PAGE using 12% gels and detected by staining the gels with Coomassie brilliant blue R-250. The dried SDS-PAGE gels were imaged and digitized with a high resolution scanner (Scanjet ADF, Hewlett Packard). The quantification of bands intensity and purity was carried out using the densitometry software (TotalLab 1.01, Nonlinear Dynamics Ltd.).
MALDI-TOF analysis of purified folding machineries
Mass spectra of purified folding catalyst proteins were collected by MALDI-TOF (Voyager-DE Biospectrometry Workstation). The purified folding machinery proteins were mixed with 3, 5-dimethyl-4-hydroxycinnamic acid as a matrix, dropped on a sample plate and air dried until crystallization occurred. Then the sample plate was loaded and analyzed the molecular weight at the proper conditions.
Preparation of denatured and reduced model proteins
For the preparation of denatured and reduced CHMO, E. coli BL21(DE3) cells containing pMM4 for CHMO expression  were grown at 37°C in LB supplemented with 100 μg/ml ampicillin. Expression was induced by adding IPTG to a final concentration of 1 mM when the culture was grown to OD600 of about 0.5. After induction for 6 hr, cells were harvested by centrifugation at 8000 × g for 30 min and resuspended in lysis buffer (10 mM Tris-HCl, 1 mM EDTA and 100 mM monobasic sodium phosphate, pH 8.0). After the cells were disrupted by being passed two times through the French Press at 20,000 psi, cell lysates were centrifuged at 12000 × g for 30 min to remove soluble proteins of E. coli and the precipitates were resuspended in washing buffer (2% Triton X-100, 20 mM EDTA and 100 mM monobasic sodium phosphate, pH 8.0). This step was repeated three times to wash out residual soluble proteins. The washed insoluble pellet was defined as CHMO inclusion body. The CHMO inclusion body and RNase A type XII-A (Sigma-Aldrich) were denatured and reduced in a solution containing 6 M guanidine hydrochloride (GdnHCl), 0.14 M DTT and 2 mM EDTA in 50 mM MOPS buffer, pH 8.0. Each solution was incubated for at least 12 hr at 25°C. The denaturation buffer was prepared just prior to use. The activities of denatured and reduced CHMO and RNase A were measured to confirm their fully denatured and reduced states.
Enzymatic activity assay
For the enzyme activity assay of RNase A, cleavage of phosphodiester bonds was monitored. RNase A (5 – 100 μl of a stock solution in 100 mM Tris-acetate buffer, pH 8.0) was added to solutions containing 2', 3'-cCMP, GdnHCl, EDTA and DTT in 50 mM Tris-acetate buffer, pH 8.0 to give a final volume of 400 μl with 4.5 mM 2', 3'- cCMP, 0.6 M GdnHCl, 0.2 mM EDTA and 14 mM DTT. The changes in absorbance were followed in thermostatic quartz cuvette (1 cm length) at 296 nm using an Ultrospec 4000 spectrophotometer (GE Healthcare Life Sciences). CHMO activity was determined from the rate of NADPH consumption upon the addition of cyclohexanone to the reaction mixture . The assay mixture contains, in a final volume of 400 μl, 40 μl of 4.0 mM NADPH, 20 μl of crude enzyme solution with 0.01 – 0.2 units of activity and 330 μl of 0.1 M Glycine/NaOH buffer, pH 9.0. An endogenous rate of NADPH consumption was measured by pre-incubation at 30°C in the thermostatic cell holder of the spectrophotometer for 2 min prior to the addition of 25 mM cyclohexanone to the assay mixture. After pre-incubation, 10 μl of cyclohexanone is added and the decrease in absorbance at 340 nm is monitored. CHMO activity was calculated as the difference between the endogenous rate of cofactor consumption and the stimulated rate of NADPH oxidation. Disulfide isomerization activity of immobilized DsbA was measured as described by the previous report with some modifications . Inactive RNase A with scrambled disulfide bonds was used for its activity recovery catalyzed by the disulfide shuffling activity of DsbA. Briefly, RNase A with scrambled disulfide bonds (final concentration, 0.2 mg/ml) was incubated in 3.6 mM GSH, 0.9 mM GSSG, 1 mM EDTA and 100 mM Tris-acetate buffer pH 8.0 in the presence or absence of immobilized DsbA. This reaction solution was mixed with 360 μl of 2', 3'-cCMP (0.1 mg/ml) in 0.1 M MOPS buffer, pH 7.0 and incubated at 25°C for 5 min. After gentle mixing, the cuvette was placed in the spectrophotometer for 20 min to allow thermal equilibration of the solution to 25°C. Hydrolysis of 2', 3'-cCMP was measured by the increase in absorption at 296 nm. The hPPIase activity was determined by a coupled assay with α-CT using the short synthetic peptide substrate, N-Suc-AAPF-p-nitroanilide in 88% trans, 12% cis configuration . The hPPIase activity was measured as the cis-trans isomerization of the alanine-proline peptide bond in the peptide. The assay relies on the inability of α-CT to hydrolyze N-Suc-AA-cis-PF-p-nitroanilide. The substrate will be rapidly hydrolyzed to N-Suc-AA-trans-PF-p-nitroanilide and released p-nitroanilide is quantified spectrophotometrically at 390 nm. The assay buffer (940 μl of 20 mM sodium phosphate buffer pH 8.0), 50 μl of gels displayed with the hPPIase protein (1.2 nmol) and the peptide substrate (20 μl of 4 mM stock solution dissolved in DMSO; final concentration 70 μM) were pre-equilibrated in the spectrophotometer for 10 min. Immediately before the assay was started, α-CT (30 μl of 2.24 mM stock solution in 1.0 mM HCl; final concentration 75 μM) solution was added. The final volume in a masked, semi-micro 1-cm path length cell was 1.0 ml. After a delay from the onset of mixing, the absorbance of p-nitroanilide was followed at 390 nm until the reaction was complete. Absorbance readings were collected on the spectrophotometer interfaced to a computer, by use of commercial data acquisition software (SWIFT, GE Healthcare Life Sciences).
Construction of refolding matrices
A cation exchanger (SP Sepharose Fast Flow) was pre-equilibrated with 50 mM sodium phosphate buffer, pH 8.4. Each folding catalyst (mini-chaperone, DsbA and hPPIase) in the same buffer was separately added to the pre-equilibrated cation exchanger and mixed for at least 2 hr with gentle shaking. The resulting refolding gels immobilized with each protein (mini-chaperone-Sepharose, DsbA-Sepharose and hPPIase-Sepharose) were thoroughly mixed in equal molar ratios of the proteins to make binary and ternary refolding gels. The unbound proteins were subsequently removed by washing with 50 mM sodium phosphate buffer, pH 8.4. In order to determine the binding capacity of folding machineries into the cation exchanger, each refolding gel immobilized with folding machineries was mixed with 2 bead volumes of 50 mM sodium phosphate buffer, pH 8.4 containing 1 M NaCl. After gentle mixing for 30 min at 25°C, the solid bead was eliminated by centrifugation. The supernatant was then subjected to the determination of protein. This procedure was repeated twice, which yield virtually the same protein concentration bound to SP Sepharose Fast Flow within the experimental error range of ± 5%.
Refolding of RNase A and CHMO
The refolding of denatured and reduced CHMO and RNase A was performed according to the method of Altamirano et al. . Refolding was initiated by equilibration of the refolding gels with refolding buffer containing 50 mM MOPS buffer, pH 8.0, 1.0 mM GSH, 0.2 mM GSSG and 14 mM DTT. In all cases, the denatured and reduced model proteins (100 μg in 40 μl) were very slowly mixed and diluted 100-fold with a resuspension of the refolding matrix and kept at 25°C under gentle mixing. After incubation for 10 min, the gel suspension was then centrifuged at 6000 × g for 10 min to separate the supernatant. The supernatants (soluble proteins) were eventually concentrated and desalted by Vivaspin concentrators (vivaspin 500; 5,000 MWCO PES, VivaScience) according to the manufacturer's instruction. The concentration and enzyme activity of refolded protein in the supernatant were determined and the amount of soluble protein was subtracted from the total proteins subjected to the initial refolding procedure to estimate the amount of aggregation. Control experiments were performed in which the denatured and reduced model proteins were added to the SP Sepharose Fast Flow equilibrated with refolding buffer alone.
Circular dichroism (CD) spectroscopy
To examine the correct folding of RNase A and CHMO, the RNase A and CHMO refolded by the ternary refolding gel were dissolved in 25 mM sodium phosphate buffer, pH 7.0 at 0.05 mg/ml. The far UV CD spectra of refolded RNase A and CHMO were monitored between 3 and 6 min at from 190 to 260 nm with a JASCO J-715 spectro-polarimeter (JASCO) using a quartz cuvette with 1 mm path length. CD spectra of native and denatured and reduced RNase A and CHMO were also recorded. Spectra were corrected by subtracting the buffer baseline and were averaged over 10 scans for far UV CD measurements.
We are grateful to Professor Jon D. Stewart (University of Florida, Gainesville, FL) for his kind donation of the plasmid pMM4. This work was supported by the Brain Korea 21 Project funded by the Ministry of Education, Science and Technology, Korea.
- Baneyx F: Recombinant protein expression in Escherichia coli. Curr Opin Biotechnol. 1999, 10: 411-421.View ArticleGoogle Scholar
- Swartz JR: Advances in Escherichia coli production of therapeutic proteins. Curr Opin Biotechnol. 2001, 12: 195-201.View ArticleGoogle Scholar
- Kane JF, Hartley DL: Properties of recombinant protein-containing inclusion bodies in Escherichia coli. Bioprocess Technol. 1991, 12: 121-145.Google Scholar
- Langenhof M, Leong SSJ, Pattenden LK, Middelberg APJ: Controlled oxidative protein refolding using an ion-exchange column. J Chromatogr A. 2005, 1069: 195-201.View ArticleGoogle Scholar
- De Bernardez Clark E, Hevehan D, Szela S, Maachupalli-Reddy J: Oxidative renaturation of hen egg-white lysozyme. Folding vs aggregation. Biotechnol Prog. 1998, 14: 47-54.View ArticleGoogle Scholar
- Kiefhaber T, Quaas R, Hahn U, Schmid FX: Folding of ribonuclease T1. 1. Existence of multiple unfolded states created by proline isomerization. Biochemistry. 1990, 29: 3053-3061.View ArticleGoogle Scholar
- Hattori M, Hiramatsu K, Kurata T, Nishiura M, Takahashi K, Ametani A, Kaminogawa S: Complete refolding of bovine β-lactoglobulin requires disulfide bond formation under strict conditions. Biochim Biophys Acta (BBA) – Proteins & Proteomics. 2005, 1752: 154-165.View ArticleGoogle Scholar
- Tan Y-J, Oliveberg M, Otzen DE, Fersht AR: The rate of isomerisation of peptidyl-proline bonds as a probe for interactions in the physiological denatured state of chymotrypsin inhibitor 2. J Mol Biol. 1997, 269: 611-622.View ArticleGoogle Scholar
- Baneyx F, Mujacic M: Recombinant protein folding and misfolding in Escherichia coli. Nature Biotechnol. 2004, 22: 1399-1408.View ArticleGoogle Scholar
- Zhao T-J, Ou W-B, Xie Q, Liu Y, Yan Y-B: Catalysis of creatine kinase refolding by protein disulfide isomerase involves disulfide cross-link and dimer to tetramer switch. J Biol Chem. 2005, 280: 13470-13476.View ArticleGoogle Scholar
- Ideno A, Furutani M, Iba Y, Kurosawa Y, Maruyama T: FK506 binding protein from the hyperthermophilic archaeon Pyrococcus horikoshii suppresses the aggregation of proteins in Escherichia coli. Appl Environ Microbiol. 2005, 68: 464-469.View ArticleGoogle Scholar
- Chatellier J, Hill F, Lund PA, Fersht AR: In vivo activities of GroEL minichaperones. Proc Natl Acad Sci USA. 1998, 95: 9861-9866.View ArticleGoogle Scholar
- Altamirano MM, Golbik R, Zahn R, Buckle AM, Fersht AR: Refolding chromatography with immobilized mini-chaperones. Proc Natl Acad Sci USA. 1997, 94: 3576-3578.View ArticleGoogle Scholar
- Kim S-G, Kim J-A, Yu H-A, Lee D-H, Kweon D-H, Seo J-H: Application of poly-arginine fused minichaperone to renaturation of cyclodextrin glycosyltransferase expressed in recombinant Escherichia coli. Enzyme Microb Technol. 2006, 39: 459-465.View ArticleGoogle Scholar
- Tsumoto K, Umetsu M, Yamada H, Ito T, Misawa S, Kumagai I: Immobilized oxidoreductase as an additive for refolding inclusion bodies: application to antibody fragments. Protein Eng. 2003, 16: 535-541.View ArticleGoogle Scholar
- Altamirano MM, Garcia C, Possani LD, Fersht AR: Oxidative refolding chromatography: folding of the scorpion toxin Cn5. Nat Biotechnol. 1999, 17: 187-191.View ArticleGoogle Scholar
- Fischer G, Bang H, Mech C: Detection of enzyme catalysis for cis-trans-isomerization of peptide bonds using proline-containing peptides as substrates. Biochim Biophys Acta (BBA). 1984, 43: 1101-1111.Google Scholar
- Secundo F, Zambianchi F, Crippa G, Carrea G, Tedeschi G: Comparative study of the properties of wild type and recombinant cyclohexanone monooxygenase, an enzyme of synthetic interest. J Mol Catal B: Enzym. 2005, 34: 1-6.View ArticleGoogle Scholar
- Wang W: Protein aggregation and its inhibition in biopharmaceutics. Int J Pharm. 2005, 289: 1-30.View ArticleGoogle Scholar
- Jungbauer A, Kaar W, Schlegl R: Folding and refolding of proteins in chromatographic beds. Curr Opin Biotechnol. 2004, 15: 487-494.View ArticleGoogle Scholar
- Morjana NA, Gilbert HF: Catalysis of protein folding by agarose-immobilized protein disulfide isomerase. Protein Expression and Purif. 1994, 5: 144-148.View ArticleGoogle Scholar
- Kweon D-H, Lee D-H, Han N-S, Rha C-S, Seo J-H: Characterization of polycationic amino acids fusion systems for ion-exchange purification of cyclodextrin glycosyltransferase from recombinant Escherichia coli. Biotechnol Prog. 2002, 18: 303-308.View ArticleGoogle Scholar
- Buchner J, Rudolph R: Renaturation, purification and characterization of recombinant Fab-fragments produced in Escherichia coli. Bio/Technology. 1991, 9: 157-162.View ArticleGoogle Scholar
- Buchner J, Brinkmann U, Pastan I: Renaturation of a single-chain immunotoxin facilitated by chaperones and protein disulfide isomerase. Bio/Technology. 1992, 10: 682-685.View ArticleGoogle Scholar
- Ferre F, Clote P: DiANNA 1.1: an extension of the DiANNA web server for ternary cysteine classification. Nucl Acids Res. 2006, 34: 182-185.View ArticleGoogle Scholar
- Sambrook J, Russell DW: Molecular cloning: a laboratory manual. 2001, New York: Cold Spring Harbor Laboratory Press, 3Google Scholar
- Walton AZ, Stewart JD: An efficient enzymatic Baeyer-Villiger oxidation by engineered Escherichia coli cells under non-growing conditions. Biotechnol Prog. 2002, 18: 262-268.View ArticleGoogle Scholar
- Trudgill PW: Cyclohexanone 1,2-monooxygenase from Acinetobacter NCIMB 9871. Methods Enzymol. 1990, 188: 70-77.View ArticleGoogle Scholar
- Akiyama Y, Kamitani S, Kusukawa N, Ito K: In vitro catalysis of oxidative folding of disulfide-bonded proteins by the Escherichia coli dsbA (ppfA) gene product. J Biol Chem. 1992, 267: 22440-22445.Google Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.